This year, researchers Megan Shen, PhD, and Mary L. “Nora” Disis, MD, of Fred Hutch Cancer Center and UW Medicine ...

8:30 a.m.–9:20 a.m. Check-in for the day and connect with fellow STTR members and guests! The confluence of technological advances and social policies has led to rapid digitization of multimodal, ...

Alt text provides a textual description of an image. It is crucial for users who are blind, visually impaired, or rely on assistive technologies. Well-written alt text enhances inclusivity and ensures ...

When Filippo Milano, MD, PhD, left his home in Italy in 2008 to further specialize in allogeneic transplantation in Seattle, it was supposed to be short-term. He would just stay long enough to learn ...

The esophagus is the organ in the throat that moves food from the mouth to the stomach. Esophageal cancers make up approximately 1% of cancer diagnoses in the U.S., making them rare. Because many ...

Over the years our annual Pathways to Health Symposium has hosted researchers and community champions to discuss important topics related to cancer health disparities. The Symposium provides a forum ...

Direct Costs are expenses directly associated with a specific research project, including lab supplies, equipment, and project-related researcher salaries. Indirect costs refer to the shared ...

After being diagnosed and treated for breast cancer three separate times, Liza Bernstein, 51, of Los Angeles has her life, her family and friends, her hopes and dreams, her art, and a renewed sense of ...

Fred Hutch was founded on the bold innovations and pioneering research that led our earliest clinicians to discover bone marrow transplantation as a cure for leukemia. Building on this Nobel ...

Pancreatic tumors are notoriously hard to treat. One of the reasons is they are filled with so much pressure that blood vessels collapse and cancer-fighting drugs can’t get in. But now researchers ...

The androgen receptor (AR) is the central therapeutic target in advanced prostate cancer. While treatments that directly target AR are effective in prolonging patient survival, aggressive prostate ...